Paper41706367
Exploring the Clinical Landscape of Long Non-coding RNAs in Cancer Diagnosis and Therapy.
Bhattacharyya R and 3 others. Biochem Genet, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Exploring the Clinical Landscape of Long Non-coding RNAs in Cancer Diagnosis and Therapy. Papers, record 41706367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41706367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exploring the Clinical Landscape of Long Non-coding RNAs in Cancer Diagnosis and Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| BT/RLF/Re-entry/47/2021 | Department of Biotechnology, Ministry of Science and Technology, India | PubMed | ||
| ANRF/ECRG/2024/000735/LS | Department of Science and Technology, Ministry of Science and Technology, India | PubMed |
Source PubMed
References223
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33444922 | Oncotype DX and Prosigna in breast cancer patients: A comparison study. | Cancer Treat Res Commun | 2021 | https://conductscience.org/library/papers/33444922 | PubMed |
| 2 | 37502440 | The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study. | Clin Exp Hepatol | 2023 | https://conductscience.org/library/papers/37502440 | PubMed |
| 3 | 37464436 | Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk. | J Exp Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37464436 | PubMed |
| 4 | 40329245 | Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40329245 | PubMed |
| 5 | 34206504 | The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34206504 | PubMed |
| 6 | 35132340 | Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients. | Dis Markers | 2022 | https://conductscience.org/library/papers/35132340 | PubMed |
| 7 | 23898077 | Circulating long non-coding RNAs in plasma of patients with gastric cancer. | Anticancer Res | 2013 | https://conductscience.org/library/papers/23898077 | PubMed |
| 8 | 38003293 | Association of SLC12A1 and GLUR4 Ion Transporters with Neoadjuvant Chemoresistance in Luminal Locally Advanced Breast Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003293 | PubMed |
| 9 | 36333703 | The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/36333703 | PubMed |
| 10 | 33329688 | Disease-Causing Mutations and Rearrangements in Long Non-coding RNA Gene Loci. | Front Genet | 2020 | https://conductscience.org/library/papers/33329688 | PubMed |
| 11 | 35729321 | Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty. | NPJ Precis Oncol | 2022 | https://conductscience.org/library/papers/35729321 | PubMed |
| 12 | 31605132 | LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression. | Carcinogenesis | 2020 | https://conductscience.org/library/papers/31605132 | PubMed |
| 13 | 28835896 | Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28835896 | PubMed |
| 14 | 35310927 | Long noncoding RNAs as promising biomarkers in cancer. | Noncoding RNA Res | 2022 | https://conductscience.org/library/papers/35310927 | PubMed |
| 15 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 16 | 39753334 | Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. | Gut | 2025 | https://conductscience.org/library/papers/39753334 | PubMed |
| 17 | 25375882 | Long non-coding RNA and epigenetic gene regulation of KSHV. | Viruses | 2014 | https://conductscience.org/library/papers/25375882 | PubMed |
| 18 | 38887279 | The role of HOTAIR in the modulation of resistance to anticancer therapy. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/38887279 | PubMed |
| 19 | 33771184 | Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis. | World J Surg Oncol | 2021 | https://conductscience.org/library/papers/33771184 | PubMed |
| 20 | 36466827 | Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections. | Front Immunol | 2022 | https://conductscience.org/library/papers/36466827 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41706367
GET https://conductscience.org/api/papers/v1/41706367/references?page=2